| Megan Elizabeth Janoff, MD | |
|
1635 Central Ave, Bridgeport, CT 06610-2717 | |
| (203) 551-7400 | |
| (203) 551-7690 |
| Full Name | Megan Elizabeth Janoff |
|---|---|
| Gender | Female |
| Speciality | Psychiatry |
| Experience | 9 Years |
| Location | 1635 Central Ave, Bridgeport, Connecticut |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1477877348 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | 051125 (Connecticut) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| State Of Connecticut | 8022915677 | 194 |
News Archive
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, driven primarily by the launch and widespread uptake of novel oral anticoagulants, the combined markets for drugs used in the treatment and prophylaxis of venous thromboembolism will experience robust growth, increasing from $2.9 billion in 2009 to more than $5 billion in 2019 in the United States, France, Germany, Italy, Spain, United Kingdom and Japan.
Delivery to the Strategic National Stockpile of the first 1 million doses of the nation's first smallpox vaccine for certain immune-compromised populations is now complete, the result of a Project BioShield contract.
Determining which patients can benefit from hip preservation surgery (rather than hip replacement surgery) is challenging, but the American Academy of Orthopaedic Surgeons recently published a hip preservation surgery appropriateness classification system.
Selexis SA, a global life science company with technologies for drug discovery, cell line development and scale-up to manufacturing of therapeutic proteins announced today that CSL Limited has entered a commercial license agreement with Selexis for the preclinical development of a therapeutic antibody anticipated to enter Phase I clinical trials in 2012.
› Verified 2 days ago
| Entity Name | State Of Connecticut |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1720013360 PECOS PAC ID: 8022915677 Enrollment ID: O20040319000785 |
News Archive
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, driven primarily by the launch and widespread uptake of novel oral anticoagulants, the combined markets for drugs used in the treatment and prophylaxis of venous thromboembolism will experience robust growth, increasing from $2.9 billion in 2009 to more than $5 billion in 2019 in the United States, France, Germany, Italy, Spain, United Kingdom and Japan.
Delivery to the Strategic National Stockpile of the first 1 million doses of the nation's first smallpox vaccine for certain immune-compromised populations is now complete, the result of a Project BioShield contract.
Determining which patients can benefit from hip preservation surgery (rather than hip replacement surgery) is challenging, but the American Academy of Orthopaedic Surgeons recently published a hip preservation surgery appropriateness classification system.
Selexis SA, a global life science company with technologies for drug discovery, cell line development and scale-up to manufacturing of therapeutic proteins announced today that CSL Limited has entered a commercial license agreement with Selexis for the preclinical development of a therapeutic antibody anticipated to enter Phase I clinical trials in 2012.
› Verified 2 days ago
| Entity Name | Prospect Waterbury Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1477902641 PECOS PAC ID: 4688967581 Enrollment ID: O20161004000255 |
News Archive
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, driven primarily by the launch and widespread uptake of novel oral anticoagulants, the combined markets for drugs used in the treatment and prophylaxis of venous thromboembolism will experience robust growth, increasing from $2.9 billion in 2009 to more than $5 billion in 2019 in the United States, France, Germany, Italy, Spain, United Kingdom and Japan.
Delivery to the Strategic National Stockpile of the first 1 million doses of the nation's first smallpox vaccine for certain immune-compromised populations is now complete, the result of a Project BioShield contract.
Determining which patients can benefit from hip preservation surgery (rather than hip replacement surgery) is challenging, but the American Academy of Orthopaedic Surgeons recently published a hip preservation surgery appropriateness classification system.
Selexis SA, a global life science company with technologies for drug discovery, cell line development and scale-up to manufacturing of therapeutic proteins announced today that CSL Limited has entered a commercial license agreement with Selexis for the preclinical development of a therapeutic antibody anticipated to enter Phase I clinical trials in 2012.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Megan Elizabeth Janoff, MD 1635 Central Ave, Bridgeport, CT 06610-2717 Ph: (203) 551-7400 | Megan Elizabeth Janoff, MD 1635 Central Ave, Bridgeport, CT 06610-2717 Ph: (203) 551-7400 |
News Archive
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, driven primarily by the launch and widespread uptake of novel oral anticoagulants, the combined markets for drugs used in the treatment and prophylaxis of venous thromboembolism will experience robust growth, increasing from $2.9 billion in 2009 to more than $5 billion in 2019 in the United States, France, Germany, Italy, Spain, United Kingdom and Japan.
Delivery to the Strategic National Stockpile of the first 1 million doses of the nation's first smallpox vaccine for certain immune-compromised populations is now complete, the result of a Project BioShield contract.
Determining which patients can benefit from hip preservation surgery (rather than hip replacement surgery) is challenging, but the American Academy of Orthopaedic Surgeons recently published a hip preservation surgery appropriateness classification system.
Selexis SA, a global life science company with technologies for drug discovery, cell line development and scale-up to manufacturing of therapeutic proteins announced today that CSL Limited has entered a commercial license agreement with Selexis for the preclinical development of a therapeutic antibody anticipated to enter Phase I clinical trials in 2012.
› Verified 2 days ago
Dr. Javier Lopez, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 267 Grant St, Bridgeport, CT 06610 Phone: 203-384-3897 Fax: 203-384-3950 | |
Raj Kumari Bansal, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 226 Mill Hill Ave, 3rd Floor, Bridgeport, CT 06610 Phone: 203-384-3873 | |
Dr. Vanja Kondev, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 340 Capitol Ave, Bridgeport, CT 06606 Phone: 203-367-5589 Fax: 203-330-0838 | |
Dr. Reginald Anthony Hoffler, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 1106 North Ave, Bridgeport, CT 06604 Phone: 203-579-6131 Fax: 203-382-8464 | |
Dr. Anthony Louis Labruzza, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 1635 Central Avenue, Southwest Connecticut Mental Health System, Bridgeport, CT 06610 Phone: 203-551-7660 Fax: 203-551-7481 | |
Joy Reyes, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 267 Grant St, Bridgeport, CT 06610 Phone: 203-384-3897 Fax: 203-384-3950 | |
Dr. David Arthur Carlson, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: Southwest Ct Mental Health System Attn Sandra Grazynski, 1635 Central Avenue, Bridgeport, CT 06610 Phone: 203-551-7660 Fax: 203-551-7481 |